Menon, Venu <br/><br/>
Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial.  [electronic resource] 

 -  Diabetes care  12 2018 
 - 2603-2609 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc18-0755  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Benzofurans--adverse effects<br/>Cardiovascular Diseases--epidemiology<br/>Cardiovascular System--metabolism<br/>Chemical and Drug Induced Liver Injury--epidemiology<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--epidemiology<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Middle Aged<br/>Sulfones--adverse effects<br/>Treatment Outcome